Bucol, Sarah Jane C.
HRN: 16-06-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2025
CEFUROXIME 750MG (VIAL)
11/19/2025
11/26/2025
IV
750mg
Q 8 Hours
Presumptive PTB
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes